SNPs within the GH-signaling pathway are associated with the early IGF1 response to GH replacement therapy in GHD adults.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  European Journal of Endocrinology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1530/EJE-13-0685PMID 24114431
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genotypes associated with lipid metabolism contribute to differences in serum lipid profile of GH-deficient adults before and after GH replacement therapy.

  2012cited by this paper
• The signal transducer and activator of transcription 5B gene polymorphism contributes to the cholesterol metabolism in Japanese children with growth hormone deficiency

  2011cited by this paper
• Models to predict changes in serum IGF1 and body composition in response to GH replacement therapy in GH-deficient adults.

  2010cited by this paper
• Rapid and high throughput genotyping of the growth hormone receptor exon 3 deleted/full-length polymorphism using a tagSNP.

  2010cited by this paper
• Influence of the exon 3-deleted/full-length growth hormone (GH) receptor polymorphism on the response to GH replacement therapy in adults with severe GH deficiency.

  2009cited by this paper
• Genetic Determinants of Height Growth Assessed Longitudinally from Infancy to Adulthood in the Northern Finland Birth Cohort 1966

  2009cited by this paper
• The d3/fl-GH receptor gene polymorphism does not influence quality of life and body composition in GH-deficient adults receiving GH replacement therapy.

  2009cited by this paper
• Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis.

  2009cited by this paper
• Association of the exon 3 deleted/full-length GHR polymorphism with recombinant growth hormone dose in growth hormone-deficient adults.

  2009cited by this paper
• Influence of the d3-growth hormone (GH) receptor isoform on short-term and long-term treatment response to GH replacement in GH-deficient adults.

  2008cited by this paper
• Association of Common JAK2 Variants With Body Fat, Insulin Sensitivity and Lipid Profile

  2008cited by this paper
• Association Analysis Indicates That a Variant GATA-Binding Site in the PIK3CB Promoter Is a Cis-Acting Expression Quantitative Trait Locus for This Gene and Attenuates Insulin Resistance in Obese Children

  2008cited by this paper
• Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II : a statement of the GH Research Society in association with the European Society for Pediatric

  2007cited by this paper
• Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer.

  2007cited by this paper
• Recent advances in growth hormone signaling

  2007cited by this paper
• Negative regulation of growth hormone receptor signaling.

  2006cited by this paper
• One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults.

  2005cited by this paper
• Regulation of Cytokine Receptor Signaling by Nuclear Hormone Receptors: A New Paradigm for Receptor Interaction

  2004cited by this paper
• Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control.

  2003cited by this paper
• Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2

  2003cited by this paper
• Signal transduction via the growth hormone receptor.

  2001cited by this paper
• Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults.

  1999cited by this paper
• Growth hormone and the metabolic syndrome.

  1999cited by this paper
• Insulin‐like growth factor‐I in growth hormone‐deficient adults: relationship to population‐based normal values, body composition and insulin tolerance test

  1997cited by this paper
• Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults

  1997cited by this paper
• The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender.

  1996cited by this paper
• Premature mortality due to cardiovascular disease in hypopituitarism.

  1990cited by this paper
• Chromosome mapping of the growth hormone receptor gene in man and mouse.

  1989cited by this paper
• Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism.

  1989cited by this paper
• Edinburgh Research Explorer Genome-wide association analysis identifies 20 loci that influence adult height

  year unknowncited by this paper

• Individual sensitivity to growth hormone replacement in adults

  2020cites this paper
• Growth Hormone Receptor Regulation in Cancer and Chronic Diseases

  2020cites this paper
• The Effect of SOCS2 Polymorphisms on Type 2 Diabetes Mellitus Susceptibility and Diabetic Complications in the Chinese Han Population

  2020cites this paper
• [Current aspects of diagnosis and treatment of adult GH-deficiency].

  2019cites this paper
• Short‐ and long‐term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism

  2019cites this paper
• Adult growth hormone deficiency: clinical advances and approaches to improve adherence

  2019cites this paper
• Personalized approach to growth hormone replacement in adults

  2019cites this paper
• Treatment with Growth Hormone for Adults with Growth Hormone Deficiency Syndrome: Benefits and Risks

  2018cites this paper
• Association between Growth Hormone-Insulin-Like Growth Factor-1 Axis Gene Polymorphisms and Short Stature in Chinese Children

  2018cites this paper
• Update on GH therapy in adults

  2017cites this paper
• MECHANISMS IN ENDOCRINOLOGY: Clinical and pharmacogenetic aspects of the growth hormone receptor polymorphism.

  2017cites this paper
• Effect of single nucleotide polymorphisms on CDK4 and Zn supplementation in children with growth hormone deficiency.

  2016cites this paper
• Growth hormone receptor isoforms and fracture risk in adult‐onset growth hormone‐deficient patients

  2016cites this paper
• Rapid method for growth hormone receptor exon 3 delete (GHRd3) SNP genotyping from archival human placental samples

  2015cites this paper
• The growth hormone receptor exon 3-deleted/full-length polymorphism and response to growth hormone therapy in prepubertal idiopathic short children.

  2015cites this paper
• Association between GH receptor polymorphism (exon 3 deletion), serum IGF1, semen quality, and reproductive hormone levels in 838 healthy young men.

  2014cites this paper
• Influence of the exon 3 deletion of GH receptor and IGF-I level at diagnosis on the efficacy and safety of treatment with somatotropin in adults with GH deficiency

  2014cites this paper
• The GH receptor exon 3 deleted/full-length polymorphism is associated with central adiposity in the general population.

  2014cites this paper
• Update on GH therapy in adults [version 1; peer review: 3 approved]

  year unknowncites this paper